These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
146 related items for PubMed ID: 11069040
1. Limitations of the diagnostic criteria for minimally differentiated acute myeloid leukemia (AML-MO). Iwata H, Kami M, Kishi Y, Oki Y, Tanaka Y, Takeuchi K, Yamazaki I, Suzuki R, Morinaga S, Mutou Y. Leukemia; 2000 Nov; 14(11):2013-4. PubMed ID: 11069040 [No Abstract] [Full Text] [Related]
2. Minimally differentiated acute myeloid leukemia (AML-MO) with lymphoid presentation at relapse: a case report. Ysebaert L, Carli PM, Casasnovas RO, Girodon F, Caillot D, Mugneret F, Maynadié M. Leukemia; 2001 Oct; 15(10):1673-4. PubMed ID: 11587233 [No Abstract] [Full Text] [Related]
3. CD7+ and CD56+ myeloid/natural killer cell precursor acute leukemia treated with idarubicin and cytosine arabinoside. Handa H, Motohashi S, Isozumi K, Komatsumoto S, Nara M. Acta Haematol; 2002 Oct; 108(1):47-52. PubMed ID: 12145468 [Abstract] [Full Text] [Related]
4. Ph-positive acute lymphoblastic leukemia after long-term remission of Ph-positive acute myeloid leukemia. Nishida H, Yoshimizu N, Ueno H, Fujita A, Kato T, Park JW, Yano T, Tobinai K, Ikeda Y. Leuk Res; 2007 Mar; 31(3):417-8. PubMed ID: 16730062 [No Abstract] [Full Text] [Related]
11. [Contribution of immunotyping in the diagnosis and in the prognosis of acute leukemia]. Merle-Béral H, Boucheix C. Rev Prat; 1996 Jan 01; 46(1):30-6. PubMed ID: 8596888 [Abstract] [Full Text] [Related]
12. Sequential quantitative MR analysis of bone marrow: differences during treatment of lymphoid versus myeloid leukemia. Vande Berg BC, Michaux L, Scheiff JM, Malghem J, Lecouvet FE, Bourgois MP, Ferrant A, Michaux JL, Maldague BE. Radiology; 1996 Nov 01; 201(2):519-23. PubMed ID: 8888252 [Abstract] [Full Text] [Related]
13. Role of FAB classification of acute leukemias in era of immunophenotyping. Sachdeva MU, Ahluwalia J, Das R, Varma N, Garewal G. Indian J Pathol Microbiol; 2006 Oct 01; 49(4):524-7. PubMed ID: 17183842 [Abstract] [Full Text] [Related]
16. [Diagnostics and therapy of acute myeloid leukemia]. Fritsch S, Metzeler K, Hiddemann W, Buske C. Dtsch Med Wochenschr; 2006 Oct 27; 131(43):2401-6. PubMed ID: 17054056 [No Abstract] [Full Text] [Related]
17. Dose-reduced induction therapy for acute leukaemias decreases both the complete remission (CR) rate and the probability of leukaemia-free survival (LFS). Krahl R, Helbig W, Kubel M. Folia Haematol Int Mag Klin Morphol Blutforsch; 1990 Oct 27; 117(6):783-6. PubMed ID: 1713882 [Abstract] [Full Text] [Related]
18. Differential chemosensitivity of leukemic cells in the myeloid and lymphoid phases of stem cell leukemia (a case report). Mihál V, Hajdúch M, Dusek J, Jarosová M, Weigl E, Pikalová Z, Indrák K, Safárová M, Janostáková A. Neoplasma; 1997 Oct 27; 44(2):133-6. PubMed ID: 9201294 [Abstract] [Full Text] [Related]
19. Lineage switch and translocation t(9;11) in acute leukemia. Van Lierde S, Mecucci C, Casteels-Van Daele M, Van den Berghe H. Am J Pediatr Hematol Oncol; 1989 Oct 27; 11(1):20-2. PubMed ID: 2712237 [Abstract] [Full Text] [Related]
20. Flow cytometric analysis of cell-surface and intracellular antigens in the diagnosis of acute leukemia. Paredes-Aguilera R, Romero-Guzman L, Lopez-Santiago N, Burbano-Ceron L, Camacho-Del Monte O, Nieto-Martinez S. Am J Hematol; 2001 Oct 27; 68(2):69-74. PubMed ID: 11559944 [Abstract] [Full Text] [Related] Page: [Next] [New Search]